SBA - Southern Biosafety Association

SBA Biosafety and Infection Prevention Journal Club

  • 05 Apr 2018
  • 5:30 PM

The Southern Biosafety Association’s Biosafety and Infection Prevention Journal Club is excited to announce the next journal club of the 2018 calendar year. Dr. Chad Austin of UTHealth has volunteered to present the paper listed below at this session. Please join us for what should be a unique discussion on a novel method of tumor treatment that uses replication-competent herpes virus. Don’t forget that remote attendance is available and very easy to access!

Andtbacka, R. H. I., Ross, M., Puzanov, I., Milhem, M., Collichio, F., Delman, K. A., … Kaufman, H. L. (2016). Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial. Annals of Surgical Oncology23(13), 4169–4177.https://doi.org/10.1245/s10434-016-5286-0  

When: Thursday, April 5th at 5:30 pm with presentation to begin at 6:00pm

Where: UTHealth Operations Control Building (OCB) – 1851 Crosspoint, Houston, TX 77054

– OR –

Remotely by Webinar or Phone!

Join WebEx meeting

https://uthealth.webex.com/join/chad.r.austin  |  806 213 302

Join by phone

+1-240-454-0887 US Toll

1-844-621-3956 US Toll free

Access code: 806 213 302

Global call-in numbers  |  Toll-free calling restrictions

Can't join the meeting?




SBA - Southern Biosafety Association

Powered by Wild Apricot Membership Software